Obesity: influence on length of hospital stay for the pediatric burn patient

Lina Patel1, John D Cowden, Denise Dowd

  • 1Division of Emergency Medicine, Department of Pediatrics, Children's Mercy Hospital and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri 64108, USA.

Insights

Childhood obesity increases length of hospital stay for pediatric burn patients. Obese children experienced a 6.5% longer hospital stay compared to nonobese children with similar burn severity.

Area of Science:

  • Pediatric Burn Care
  • Obesity Comorbidities
  • Public Health

Background:

  • Childhood obesity is a significant public health issue with known comorbidities.
  • Obesity's impact on adult burn outcomes includes functional deficits and increased mortality.
  • Limited data exists on how obesity affects pediatric burn patients.

Purpose of the Study:

  • To determine the effect of obesity on length of hospital stay (LOS) in pediatric burn patients.
  • To compare burn characteristics between obese and nonobese pediatric burn patients.

Main Methods:

  • Retrospective cohort study of 528 pediatric burn patients (0-18 years).
  • Obesity defined by weight-for-length or body mass index (BMI) at or above the 95th percentile.
  • Linear regression analysis adjusted for factors including burn size, burn depth, and insurance status.

Main Results:

  • 17.4% of pediatric burn patients were obese.
  • Obese patients had a higher likelihood of burns in high-risk areas.
  • Obese children had a significantly longer median LOS (9.3 vs 7.1 days).
  • After adjustment, obesity was associated with a 6.5% increase in LOS.

Conclusions:

  • Obesity is an independent factor associated with increased length of hospital stay in pediatric burn patients.
  • Further research is needed to identify specific mechanisms driving longer LOS in obese children, such as complications or healing rates.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...